Purple Biotech Ltd.PPBTNASDAQ
Loading
Debt to Assets Over TimeNormalizing
Percentile Rank36
3Y CAGR-22.6%
5Y CAGR-20.1%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
-22.6%/yr
Annual compound
5Y CAGR
-20.1%/yr
Consistent
Percentile
P36
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
5 yr
Consecutive declineNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.00 | -37.6% |
| 2023 | 0.01 | -16.0% |
| 2022 | 0.01 | -11.6% |
| 2021 | 0.01 | -0.1% |
| 2020 | 0.01 | -29.5% |
| 2019 | 0.02 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |
| 2015 | 0.00 | - |